Tricaine mesylate

Tricaine mesylate

Clinical data
Synonyms	Metacaine Tricaine MS-222 Finquel TMS
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Identifiers
IUPAC name Ethyl 3-aminobenzoate methanesulfonic acid
CAS Number	886-86-2 Y
PubChem CID	13454
ChemSpider	12878 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C10H15NO5S
Molar mass	261.296 g/mol
3D model (JSmol)	Interactive image
Melting point	149.5 °C (301.1 °F)
SMILES [NH3+]C1=CC=CC(C(OCC)=O)=C1.CS(=O)([O-])=O
InChI InChI=1S/C9H11NO2.CH4O3S/c1-2-12-9(11)7-4-3-5-8(10)6-7;1-5(2,3)4/h3-6H,2,10H2,1H3;1H3,(H,2,3,4) N Key:FQZJYWMRQDKBQN-UHFFFAOYSA-N N
NY (what is this?)  (verify)

WikiDoc Resources for Tricaine mesylate
Articles
Most recent articles on Tricaine mesylate Most cited articles on Tricaine mesylate Review articles on Tricaine mesylate Articles on Tricaine mesylate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tricaine mesylate Images of Tricaine mesylate Photos of Tricaine mesylate Podcasts & MP3s on Tricaine mesylate Videos on Tricaine mesylate
Evidence Based Medicine
Cochrane Collaboration on Tricaine mesylate Bandolier on Tricaine mesylate TRIP on Tricaine mesylate
Clinical Trials
Ongoing Trials on Tricaine mesylate at Clinical Trials.gov Trial results on Tricaine mesylate Clinical Trials on Tricaine mesylate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tricaine mesylate NICE Guidance on Tricaine mesylate NHS PRODIGY Guidance FDA on Tricaine mesylate CDC on Tricaine mesylate
Books
Books on Tricaine mesylate
News
Tricaine mesylate in the news Be alerted to news on Tricaine mesylate News trends on Tricaine mesylate
Commentary
Blogs on Tricaine mesylate
Definitions
Definitions of Tricaine mesylate
Patient Resources / Community
Patient resources on Tricaine mesylate Discussion groups on Tricaine mesylate Patient Handouts on Tricaine mesylate Directions to Hospitals Treating Tricaine mesylate Risk calculators and risk factors for Tricaine mesylate
Healthcare Provider Resources
Symptoms of Tricaine mesylate Causes & Risk Factors for Tricaine mesylate Diagnostic studies for Tricaine mesylate Treatment of Tricaine mesylate
Continuing Medical Education (CME)
CME Programs on Tricaine mesylate
International
Tricaine mesylate en Espanol Tricaine mesylate en Francais
Business
Tricaine mesylate in the Marketplace Patents on Tricaine mesylate
Experimental / Informatics
List of terms related to Tricaine mesylate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tricaine mesylate (Tricaine methanesulfonate, TMS, MS-222), is white powder used for anesthesia, sedation, or euthanasia of fish. TMS is the only anesthetic licensed in the United States for fin fish that are intended for human consumption. The drug can have selective toxicity for poikilotherms due to their lower rate of metabolism in the liver.

TMS is a muscle relaxant that operates by preventing action potentials.By blocking action potentials, no signals can be exchanged between the brain and the extremities. There will be no sensory input or muscle contractions which would have been caused by action potential, which includes most muscles.

The optimum concentration may vary with the size and species of the fish, and other variables.

It is easily soluble in water (both fresh and salt) but it drastically decreases the pH of water, increasing the acidity, which may be toxic for fish. Sodium bicarbonate can be used to buffer the solution to a pH range of 6.5-7.5. Usually an equal amount of buffer is added to attain a neutral pH. In salt/marine/sea water, the buffer use may not be necessary because sea water itself has buffering capacity.

The solution of TMS needs to be prepared freshly each time because TMS is light-sensitive and might form toxic by-products upon exposure to light.